Selected article for: "aspartate aminotransferase and blood count"
Author: Huang, Yun; Zhang, Yuyu; Ma, Lili
Title: Meta-analysis of laboratory results in patients with severe coronavirus disease 2019
  • Cord-id: yzjfnzls
  • Document date: 2021_3_1
    • ID: yzjfnzls
    Snippet: The aim of the present study was to analyze the differences in laboratory results between patients with severe and moderate coronavirus disease 2019 (COVID-19) for clinical intervention. The laboratory results of patients with COVID-19 between December 2019 and May 2020 were assembled from the Medline, Embase and Cochrane Library databases. A meta-analysis was conducted, calculating the individual and pooled odds ratios (ORs) with relative 95% confidence intervals (95% CIs) using Review Manager
    Document: The aim of the present study was to analyze the differences in laboratory results between patients with severe and moderate coronavirus disease 2019 (COVID-19) for clinical intervention. The laboratory results of patients with COVID-19 between December 2019 and May 2020 were assembled from the Medline, Embase and Cochrane Library databases. A meta-analysis was conducted, calculating the individual and pooled odds ratios (ORs) with relative 95% confidence intervals (95% CIs) using Review Manager 5.3. The available data of 1,534 patients from 6 studies were included in this analysis. The results demonstrated that the incidence of leukocytosis, lymphocytopenia, increased procalcitonin (PCT), C-reactive protein (CRP), aspartate aminotransferase (AST) and lactic dehydrogenase (LDH) levels was associated with a nearly 3-fold (OR=3.44; 95% CI: 2.15-5.49), 4-fold (OR=4.39; 95% CI: 1.82-10.60), 5-fold (OR=5.28; 95% CI: 3.42-8.15), 4-fold (OR=3.99; 95% CI: 2.61-6.12), 3-fold (OR=3.02; 95% CI: 2.13-4.26) and 8-fold (OR=8.33; 95% CI: 1.75-39.69) higher risk of severe COVID-19 infection, respectively. These findings indicated that serial white blood cell count, lymphocyte count, CRP, PCT, LDH and AST measurements may be useful for predicting progression towards a more severe form of COVID-19.

    Search related documents:
    Co phrase search for related documents
    • abnormal finding and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4
    • abstract title and acute respiratory distress syndrome: 1
    • abstract title and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • abstract title and additional study: 1, 2
    • abstract title and liver function: 1
    • activate immunity and acute respiratory distress syndrome: 1
    • activate immunity and acute sars cov respiratory syndrome coronavirus: 1, 2, 3
    • activate immunity and liver tissue: 1
    • activate immunity and liver tissue injury: 1
    • activator protein and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7
    • activator protein and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5
    • activator protein and liver tissue: 1
    • acute respiratory distress syndrome and additional study: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory distress syndrome and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • acute respiratory distress syndrome and liver function impairment: 1, 2
    • acute respiratory distress syndrome and liver tissue: 1, 2, 3, 4, 5
    • acute respiratory distress syndrome and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress syndrome result and liver tissue: 1
    • acute sars cov respiratory syndrome coronavirus and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25